Boston Scientific Corporation Price Today
Boston Scientific Corporation
BSX
Healthcare
$100.97B
💰
Market Cap
64.2
💸
Price to Earnings
$1.1
🎉
EPS
+77
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
20 |
Strong Buy |
13 |
Hold |
4 |
Sell |
0 |
Strong Sell |
0 |
BSX Price Forecast Target
68.7 👉 81.0 +18%
BSX EPS Forecast
1.1 👉 2.5 +138%
Financials
Profit Margin
11 %
Revenue Growth
14.9 %
Dividend
$ 0
Held Percent
0.2% - Insiders
93.7% - Institutions
6.1% - Public
Major Fund Holders
-
💰 FMR, LLC $9.5B
-
💰 Blackrock Inc. $8.7B
-
💰 Vanguard Group Inc $8.6B
-
💰 State Street Corporation $4.3B
-
💰 Massachusetts Financial Services Co. $3.9B
Stock Ideas
Paul Tudor Jones Portfolio
Paul Tudor Jones is a pioneer in macro trading and founder of Tudor Investment Corporation, one of the earliest pioneering hedge funds. With over 40 years of experience investing across global markets, Jones strategically allocates capital based on …
Daniel Loeb Portfolio
Daniel Loeb is an American billionaire businessman and founder/CEO of Third Point LLC, a global investment firm managing over $12 billion in assets through long/short equity investments and activism. As one of the world's most successful hedge fund…
Michael Burry Portfolio
Michael Burry, the renowned value investor and founder of Scion Asset Management, gained limited recognition until his story was documented in Michael Lewis' bestseller 'The Big Short.' Despite predicting the subprime mortgage crisis, Scion's AUM fe…
Jim Simons Portfolio
Jim Simons, the mastermind behind the Medallion Fund, has achieved such extraordinary returns that he has skyrocketed to the ranks of the world's wealthiest individuals. The secret to his success lies in the fund's implementation of high-frequency t…📮FAQ
Some Frequently Asked Questions.
The Boston Scientific Corporation industry is Medical Devices
The Boston Scientific Corporation sector is Healthcare
The Boston Scientific Corporation forecasted predicted Price to Earnings PE ratio is 26.9
The Boston Scientific Corporation Price to Earnings PE ratio is 64.2
The Market Capitalization of Boston Scientific Corporation is $100.97B
There are total of 1462195528 float shares with 93.7% held by Institutions and 0.2% held by insiders
The MBoston Scientific Corporation forecasted Earnings per Share EPS is $2.5
The Boston Scientific Corporation Earnings per Share EPS is 1.1
The Boston Scientific Corporation company has $0 gross profits with 11 profit margins
The Boston Scientific Corporation Earnings Growth is 2.856% with 2.6% quarterly earnings growth
The Boston Scientific Corporation Revenue is $14240000000 with 0.149 revenue growth
The price target for Boston Scientific Corporation stock is $81.0 for the high target and $63.0 for the low target
The consensus analyst recommendations for Boston Scientific Corporation is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Boston Scientific Corporation is Buy, with the following breakdown:
- Buy: 20
- Strong Buy: 13
- Hold: 4
- Sell: 0
- Strong Sell: 0
The Beta of Boston Scientific Corporation is 0.8
The dividend of Boston Scientific Corporation is $0
The dividend yield of Boston Scientific Corporation is 0%
The biggest institutional and mutual fund holders of Boston Scientific Corporation stock are
- FMR, LLC
- Blackrock Inc.
- Vanguard Group Inc
- State Street Corporation
The Boston Scientific Corporation ESG Score is 77, with the following breakdown:
- E: 2.36
- S: 11.85
- G: 8.89